Gonadotropins: A cohesive gender-based etiology of Alzheimer disease

Molecular and Cellular Endocrinology

Volumn 260-262, Issue , 2007, Pages 271-275

  Webber, Kate M ^a   Casadesus, Gemma ^a   Atwood, Craig S ^b   Bowen, Richard L ^c,d   Perry, George ^a   Smith, Mark A ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^c Voyager Pharmaceutical Corporation   (United States)

^d University of Texas at San Antonio ^*

Author keywords

Alzheimer disease; Andropause; Estrogen; Gonadotropins; Leuprolide acetate; Luteinizing hormone; Menopause

Indexed keywords

ESTROGEN; GESTAGEN; GONADOTROPIN; LEUPRORELIN; LUTEINIZING HORMONE; STEROID HORMONE;

ALZHEIMER DISEASE; AMNESIA; CLINICAL TRIAL; DEPRESSION; HORMONE SUBSTITUTION; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN FOLDING; REVIEW;

ALZHEIMER DISEASE; GONADOTROPIN-RELEASING HORMONE; GONADOTROPINS; GONADS; HUMANS; HYPOTHALAMUS; PITUITARY GLAND; SEX CHARACTERISTICS;

EID: 33751251056     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2006.01.018     Document Type: Review

References (48)

1. Apaja P.M., Harju K.T., Aatsinki J.T., Petaja-Repo U.E., and Rajaniemi H.J. Identification and structural characterization of the neuronal luteinizing hormone receptor associated with sensory systems. J. Biol. Chem. 279 (2004) 1899-1906
2. Bhavnani B.R. Estrogens and menopause: pharmacology of conjugated equine estrogens and their potential role in the prevention of neurodegenerative diseases such as Alzheimer's. J. Steroid. Biochem. Mol. Biol. 85 (2003) 473-482
3. Bowen R.L., Isley J.P., and Atkinson R.L. An association of elevated serum gonadotropin concentrations and Alzheimer disease?. J. Neuroendocrinol. 12 (2000) 351-354
4. Bowen R.L. Sex hormones, amyloid protein, and Alzheimer disease. JAMA 286 (2001) 790-791
5. Bowen R.L., Smith M.A., Harris P.L., Kubat Z., Martins R.N., Castellani R.J., Perry G., and Atwood C.S. Elevated luteinizing hormone expression colocalizes with neurons vulnerable to Alzheimer's disease pathology. J. Neurosci. Res. 70 (2002) 514-518
6. Bowen R.L., Atwood C.S., Perry G., and Smith M.A. Mechanisms involved in gender differences in Alzheimer's disease: the role of leuteinizing and follicle stimulating hormones. In: Legato M.L. (Ed). Principles of Gender Specific Medicine (2004), Academic Press, San Diego 1234-1237
7. Bowen R.L., Verdile G., Liu T., Parlow A.F., Perry G., Smith M.A., Martins R.N., and Atwood C.S. Luteinizing hormone, a reproductive regulator that modulates the processing of amyloid-beta precursor protein and amyloid-beta deposition. J. Biol. Chem. 279 (2004) 20539-20545
8. Bowen R.L., Martins R.N., Gregory C.W., Smith M.A., and Atwood C.S. Dementia and testosterone levels in men. JAMA 293 (2005) 551 (author reply 552)
9. Boyar R., Finkelstein J., Roffwarg H., Kapen S., Weitzman E., and Hellman L. Synchronization of augmented luteinizing hormone secretion with sleep during puberty. N. Engl. J. Med. 287 (1972) 582-586
10. Breitner J.C., Silverman J.M., Mohs R.C., and Davis K.L. Familial aggregation in Alzheimer's disease: comparison of risk among relatives of early- and late-onset cases, and among male and female relatives in successive generations. Neurology 38 (1988) 207-212
11. Casadesus G., Zhu X., Atwood C.S., Webber K.M., Perry G., Bowen R.L., and Smith M.A. Beyond estrogen: targeting gonadotropin hormones in the treatment of Alzheimer's disease. Curr. Drug Targets CNS Neurol. Disord. 3 (2004) 281-285
12. Casadesus G., Atwood C.S., Zhu X., Hartzler A.W., Webber K.M., Perry G., Bowen R.L., and Smith M.A. Evidence for the role of gonadotropin hormones in the development of Alzheimer disease. Cell. Mol. Life Sci. 62 (2005) 293-298
13. Chakravarti S., Collins W.P., Forecast J.D., Newton J.R., Oram D.H., and Studd J.W. Hormonal profiles after the menopause. Br. Med. J. 2 (1976) 784-787
14. Couzinet B., and Schaison G. The control of gonadotrophin secretion by ovarian steroids. Hum. Reprod. 8 Suppl. 2 (1993) 97-101
15. Ernst R.L., and Hay J.W. The US economic and social costs of Alzheimer's disease revisited. Am. J. Public Health 84 (1994) 1261-1264
16. Fratiglioni L., Viitanen M., von Strauss E., Tontodonati V., Herlitz A., and Winblad B. Very old women at highest risk of dementia and Alzheimer's disease: incidence data from the Kungsholmen Project, Stockholm. Neurology 48 (1997) 132-138
17. Genazzani A.R., Gastaldi M., Bidzinska B., Mercuri N., Genazzani A.D., Nappi R.E., Segre A., and Petraglia F. The brain as a target organ of gonadal steroids. Psychoneuroendocrinology 17 (1992) 385-390
18. Harris P.L., Zhu X., Pamies C., Rottkamp C.A., Ghanbari H.A., McShea A., Feng Y., Ferris D.K., and Smith M.A. Neuronal polo-like kinase in Alzheimer disease indicates cell cycle changes. Neurobiol. Aging 21 (2000) 837-841
19. Hebert L.E., Scherr P.A., Bienias J.L., Bennett D.A., and Evans D.A. Alzheimer disease in the US population: prevalence estimates using the 2000 census. Arch. Neurol. 60 (2003) 1119-1122
20. Hogervorst E., Combrinck M., and Smith A.D. Testosterone and gonadotropin levels in men with dementia. Neuroendocrinol. Lett. 24 (2003) 203-208
21. Jorm A.F., Korten A.E., and Henderson A.S. The prevalence of dementia: a quantitative integration of the literature. Acta Psychiatr. Scand. 76 (1987) 465-479
22. Jorm A.F., and Jolley D. The incidence of dementia: a meta-analysis. Neurology 51 (1998) 728-733
23. Lei Z.M., Rao C.V., Kornyei J.L., Licht P., and Hiatt E.S. Novel expression of human chorionic gonadotropin/luteinizing hormone receptor gene in brain. Endocrinology 132 (1993) 2262-2270
24. Letenneur L., Commenges D., Dartigues J.F., and Barberger-Gateau P. Incidence of dementia and Alzheimer's disease in elderly community residents of south-western France. Int. J. Epidemiol. 23 (1994) 1256-1261
25. McGonigal G., Thomas B., McQuade C., Starr J.M., MacLennan W.J., and Whalley L.J. Epidemiology of Alzheimer's presenile dementia in Scotland, 1988. Br. Med. J. 306 (1993) 680-683
26. McShea A., Harris P.L., Webster K.R., Wahl A.F., and Smith M.A. Abnormal expression of the cell cycle regulators P16 and CDK4 in Alzheimer's disease. Am. J. Pathol. 150 (1997) 1933-1939
27. McShea A., Zelasko D.A., Gerst J.L., and Smith M.A. Signal transduction abnormalities in Alzheimer's disease: evidence of a pathogenic stimuli. Brain Res. 815 (1999) 237-242
28. Neaves W.B., Johnson L., Porter J.C., Parker Jr. C.R., and Petty C.S. Leydig cell numbers, daily sperm production, and serum gonadotropin levels in aging men. J. Clin. Endocrinol. Metab. 59 (1984) 756-763
29. Nunomura A., Perry G., Aliev G., Hirai K., Takeda A., Balraj E.K., Jones P.K., Ghanbari H., Wataya T., Shimohama S., Chiba S., Atwood C.S., Petersen R.B., and Smith M.A. Oxidative damage is the earliest event in Alzheimer disease. J. Neuropathol. Exp. Neurol. 60 (2001) 759-767
30. Ogawa O., Lee H.G., Zhu X., Raina A., Harris P.L., Castellani R.J., Perry G., and Smith M.A. Increased p27, an essential component of cell cycle control, in Alzheimer's disease. Aging Cell 2 (2003) 105-110
31. Ogawa O., Zhu X., Lee H.G., Raina A., Obrenovich M.E., Bowser R., Ghanbari H.A., Castellani R.J., Perry G., and Smith M.A. Ectopic localization of phosphorylated histone H3 in Alzheimer's disease: a mitotic catastrophe?. Acta Neuropathol. (Berl.) 105 (2003) 524-528
32. Raina A.K., Zhu X., Rottkamp C.A., Monteiro M., Takeda A., and Smith M.A. Cyclin' toward dementia: cell cycle abnormalities and abortive oncogenesis in Alzheimer disease. J. Neurosci. Res. 61 (2000) 128-133
33. Rapp S.R., Espeland M.A., Shumaker S.A., Henderson V.W., Brunner R.L., Manson J.E., Gass M.L., Stefanick M.L., Lane D.S., Hays J., Johnson K.C., Coker L.H., Dailey M., and Bowen D. Effect of estrogen plus progestin on global cognitive function in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial. JAMA 289 (2003) 2663-2672
34. Rocca W.A., Hofman A., Brayne C., Breteler M.M., Clarke M., Copeland J.R., Dartigues J.F., Engedal K., Hagnell O., Heeren T.J., et al. Frequency and distribution of Alzheimer's disease in Europe: a collaborative study of 1980-1990 prevalence findings. The EURODEM-Prevalence Research Group. Ann. Neurol. 30 (1991) 381-390
35. Sherwin B.B., and Tulandi T. "Add-back" estrogen reverses cognitive deficits induced by a gonadotropin-releasing hormone agonist in women with leiomyomata uteri. J. Clin. Endocrinol. Metab. 81 (1996) 2545-2549
36. Short R.A., Bowen R.L., O'Brien P.C., and Graff-Radford N.R. Elevated gonadotropin levels in patients with Alzheimer disease. Mayo Clin. Proc. 76 (2001) 906-909
37. Shumaker S.A., Legault C., Rapp S.R., Thal L., Wallace R.B., Ockene J.K., Hendrix S.L., Jones III B.N., Assaf A.R., Jackson R.D., Kotchen J.M., Wassertheil-Smoller S., and Wactawski-Wende J. Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial. JAMA 289 (2003) 2651-2662
38. Smith M.A. Alzheimer disease. Int. Rev. Neurobiol. 42 (1998) 1-54
39. Smith M.A., Perry G., Atwood C.S., and Bowen R.L. Estrogen replacement and risk of Alzheimer disease. JAMA 289 (2003) 1100 (author reply 1101-2)
40. Varney N.R., Syrop C., Kubu C.S., Struchen M., Hahn S., and Franzen K. Neuropsychologic dysfunction in women following leuprolide acetate induction of hypoestrogenism. J. Assist. Reprod. Genet. 10 (1993) 53-57
41. Webber K.M., Bowen R., Casadesus G., Perry G., Atwood C.S., and Smith M.A. Gonadotropins and Alzheimer's disease: the link between estrogen replacement therapy and neuroprotection. Acta Neurobiol. Exp. (Warsz) 64 (2004) 113-118
42. Webber K.M., Casadesus G., Marlatt M.W., Perry G., Hamlin C.R., Atwood C.S., Bowen R.L., and Smith M.A. Estrogen bows to a new master: the role of gonadotropins in Alzheimer pathogenesis. Ann. N. Y. Acad. Sci. 1052 (2005) 201-209
43. Webber K.M., Casadesus G., Perry G., Atwood C.S., Bowen R., and Smith M.A. Gender differences in Alzheimer disease: the role of luteinizing hormone in disease pathogenesis. Alzheimer Dis. Assoc. Disord. 19 (2005) 95-99
44. Welt C., Sidis Y., Keutmann H., and Schneyer A. Activins, inhibins, and follistatins: from endocrinology to signalling. A paradigm for the new millennium. Exp. Biol. Med. (Maywood) 227 (2002) 724-752
45. Zhu X., Raina A.K., and Smith M.A. Cell cycle events in neurons. Proliferation or death?. Am. J. Pathol. 155 (1999) 327-329
46. Zhu X., Rottkamp C.A., Raina A.K., Brewer G.J., Ghanbari H.A., Boux H., and Smith M.A. Neuronal CDK7 in hippocampus is related to aging and Alzheimer disease. Neurobiol. Aging 21 (2000) 807-813
47. Zhu X., McShea A., Harris P.L., Raina A.K., Castellani R.J., Funk J.O., Shah S., Atwood C., Bowen R., Bowser R., Morelli L., Perry G., and Smith M.A. Elevated expression of a regulator of the G2/M phase of the cell cycle, neuronal CIP-1-associated regulator of cyclin B, in Alzheimer's disease. J. Neurosci. Res. 75 (2004) 698-703
48. Zhu X., Webber K.M., Casadesus G., Raina A.K., Lee H.G., Marlatt M., Hartzler A., Atwood C.S., Perry G., and Smith M.A. Mitotic and gender parallels in Alzheimer disease: therapeutic opportunities. Curr. Drug Targets 5 (2004) 559-563